University of Massachusetts Amherst

ScholarWorks@UMass Amherst
Masters Theses 1911 - February 2014
2009

Dopamine Controls Locomotion by Modulating the Activity of the
Cholinergic Motor Neurons in C. elegans
Andrew T. Allen
University of Massachusetts Amherst

Follow this and additional works at: https://scholarworks.umass.edu/theses
Part of the Behavioral Neurobiology Commons, Biochemistry Commons, Molecular and Cellular
Neuroscience Commons, and the Molecular Biology Commons

Allen, Andrew T., "Dopamine Controls Locomotion by Modulating the Activity of the Cholinergic Motor
Neurons in C. elegans" (2009). Masters Theses 1911 - February 2014. 309.
Retrieved from https://scholarworks.umass.edu/theses/309

This thesis is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for
inclusion in Masters Theses 1911 - February 2014 by an authorized administrator of ScholarWorks@UMass
Amherst. For more information, please contact scholarworks@library.umass.edu.

DOPAMINE CONTROLS LOCOMOTION BY MODULATING THE ACTIVITY OF
THE CHOLINERGIC MOTOR NEURONS IN C. ELEGANS

A Thesis Presented
by
ANDREW T. ALLEN

Submitted to the Graduate School of the
University of Massachusetts Amherst in partial fulfillment
of the requirements for the degree of
MASTER OF SCIENCE
May 2009
Biochemistry and Molecular Biology

© Copyright by Andrew T. Allen 2009
All Rights Reserved

DOPAMINE CONTROLS LOCOMOTION BY MODULATING THE ACTIVITY OF
THE CHOLINERGIC MOTOR NEURONS IN C. ELEGANS

A Thesis Presented
by
ANDREW T. ALLEN

Approved as to style and content by:

______________________________________
Daniel L. Chase, Chair
______________________________________
Rolf O. Karlstrom, Member
______________________________________
Alice Y. Cheung, Member

___________________________________
Danny J. Schnell, Department Head
Biochemistry and Molecular Biology

DEDICATION
To Donnie Johnson: you’d better be smiling up there.

ACKNOWLEDGMENTS
I would like to thank Kathryn Maher, Khursheed Wani, and Katherine Betts for
advice, assistance, and discussion; scientific or otherwise. Also, I would like to thank my
family for their love, support, and confidence. Finally, I would like to thank Daniel
Chase for instilling in me a passion for meticulous and exacting science: better late than
never.

v

ABSTRACT
DOPAMINE CONTROLS LOCOMOTION BY MODULATING THE ACTIVITY OF
THE CHOLINERGIC MOTOR NEURONS IN C. ELEGANS
MAY 2009
ANDREW T. ALLEN M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Daniel L. Chase

Dopamine is an important neurotransmitter in the brain, where it plays a
regulatory role in the coordination of movement and cognition by acting through two
classes of G protein-coupled receptors to modulate synaptic activity. In addition, it has
been shown these two receptor classes can exhibit synergistic or antagonistic effects on
neurotransmission. However, while the pharmacology of the mammalian dopamine
receptors have been characterized in some detail, less is known about the molecular
pathways that act downstream of the receptors. As in mammals, the soil nematode
Caenorhabditis elegans uses two classes of dopamine receptors to control neural activity
and thus can serve as a genetic tool to identify the molecular mechanisms through which
dopamine receptors exert their effects on neurotransmission. To identify novel
components of mammalian dopamine signaling pathways, we conducted a genetic screen
for C. elegans mutants defective in exogenous dopamine response. We screened 31,000
mutagenized haploid genomes and recovered seven mutants. Five of these mutants were
in previously-identified dopamine signaling genes, including those encoding the Gα
proteins GOA-1 (ortholog of human Gαo) and EGL-30 (ortholog of human Gαq), the
diacylglycerol kinase DGK-1 (ortholog of human DGKθ), and the dopamine receptor
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DOP-3 (ortholog of human D2-like receptor). In addition to these known components, we
identified mutations in the glutamate-gated cation channel subunit GLR-1 (ortholog of
human AMPA receptor subunits) and the class A acetylcholinesterase ACE-1 (ortholog
of human acetylcholinesterase). Behavioral analysis of these mutants demonstrates that
dopamine signaling controls acetylcholine release by modulating the excitability of the
cholinergic motor neurons in C. elegans through two antagonistic dopamine receptor
signaling pathways, and that this antagonism occurs within a single cell. In addition, a
mutation in the putative Rab GTPase activating protein TBC-4 was identified, which may
suggest a role for this Rab GAP in synaptic vesicle trafficking. Subsequent behavioral
and genetic analyses of mutants in synaptic vesicular trafficking components implicate
RAB-3-mediated vesicular trafficking in DOP-3 receptor signaling. These results
together suggest a possible mechanism for the regulation of dopamine receptor signaling
by vesicular trafficking components in the cholinergic motor neurons of C. elegans.
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CHAPTER I
INTRODUCTION
Dopamine signaling in mammals
Dopamine is a neurotransmitter whose importance in regulating neural activity in
the mammalian brain is well established. In mammals, dopamine binds to five seven
transmembrane heterotrimeric G-protein coupled receptors to exert its effects on
neurotransmission. These five mammalian dopamine receptors have been grouped into
two classes based on biochemical and pharmacological criteria: D1-like and D2-like.
Previously, it has been shown in mammals that D1-like and D2-like receptors can
have both antagonistic and synergistic effects on neurotransmission (Missale et al. 1998).
D1-like receptors increase the excitability of the neuron by stimulating cyclic AMPdependent processes or by increasing the availability of intracellular calcium, whereas
D2-like receptors attenuate the excitability of the neuron by counteracting these processes
(Neve et al. 2004). Additionally, D1-like and D2-like receptors can form heterooligomers through which unique physiological responses can be elicited (Lee et al. 2004).
While the downstream effects of these receptors on neural activity have been heavily
investigated both in vivo and in vitro, the molecular mechanisms through which
dopamine receptor signaling influences neurotransmission remain largely undiscovered,
in part due to the lack of a genetically tractable model organism with which to answer
these questions.
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Dopamine signaling in C. elegans
The soil nematode C. elegans is an excellent tool for the genetic analysis of
neurotransmission with a simple nervous system consisting of 302 neurons (White et al.
1986). Eight of these neurons synthesize dopamine (Sulston et al. 1975), and it has been
shown that in response to mechanical stimulation these neurons release dopamine which
functions extrasynaptically to control locomotion (Sawin et al. 2000; Chase et al. 2004).
Importantly, many components of G-protein coupled receptor signaling in the
mammalian brain have homologs in C. elegans, suggesting that the molecular
mechanisms mediating dopamine signaling in the worm may be conserved in mammals.
Among these conserved components are the dopamine receptors DOP-1 and DOP-3,
which are homologous to the D1 and D2-like receptors present in the mammalian brain,
respectively (Suo et al. 2002; Sugiura et al. 2005). These two receptors are co-expressed
in the cholinergic motor neurons of C. elegans, where DOP-3 signals through the Gαo
homolog GOA-1 to inhibit locomotion, and DOP-1 antagonizes DOP-3 signaling by
positively regulating locomotion through the Gαq homolog EGL-30 (Lackner et al. 1999;
Chase et. al. 2004). These observations firmly establish the cholinergic motor neuron of
C. elegans as a model system to investigate the antagonistic mechanism of dopamine
signaling.
Exposure of C. elegans to high levels of exogenous dopamine causes paralysis by
acting through the DOP-3 receptor, and it has been shown that mutants in the molecular
components responsible for inhibiting locomotion in response to dopamine are resistant
to these paralytic effects (Chase et al. 2004). Therefore, forward genetic approaches can
be used to isolate additional components of dopamine signaling pathways in C. elegans
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using exogenous dopamine resistance as a selective criteria. Such screens have been
done previously and have succeeded in identifying several components of dopamine
signaling in C. elegans conserved in mammals (Chase et al. 2004). However, dop-3
mutants were not isolated in these screens, and given the importance of the DOP-3
receptor in the exogenous dopamine response, we reasoned that there may be additional
components of dopamine signaling that remain unidentified. Therefore, we conducted a
modified genetic screen to isolate additional components of the exogenous dopamine
response. As a result of our screen, we have established that dopamine controls the
release of acetylcholine by modulating the excitability of the cholinergic motor neurons
through two antagonistic dopamine receptor signaling pathways, and that this antagonism
occurs within a single cell.
Rab GTPases and their putative role in dopamine signaling
Rab GTPases are important molecular switches that regulate the transport,
docking, and fusion of vesicles in many cellular processes (Fukuda 2008), and Rab
activity can be modified by several additional proteins. Guanine nucleotide exchange
factors (GEFs) enhance a Rab protein’s association with vesicular membranes, and Rab
GTPase activating proteins (Rab GAPs) enhance the intrinsic GTPase activity of the Rab
protein, resulting in the dissociation of the Rab protein from the membrane to which it is
bound.
Two Rab GTPases in C. elegans have been localized to the pre-synaptic terminals
of cholinergic motor neurons: RAB-3 (homolog of mammalian Rab3A) and AEX-6
(homolog of mammalian Rab27A). Both RAB-3 and AEX-6 have been shown to play
important roles in synaptic transmission in C. elegans (Nonet et al. 1997; Mahoney et al.
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2006), and Rab3A has been shown to work in a similar capacity in mammals (Geppert et
al. 1997, Leenders et al. 2001, Wang et al. 2008). However, the subtle behavioral defects
of rab-3 mutants combined with an incomplete mechanistic understanding of AEX-6mediated vesicular docking raise interesting questions as to exactly how RAB-3 and
AEX-6 facilitate neurotransmission.
As a result of our genetic screen for mutants resistant to exogenous dopamine, we
identified a mutant in the tbc-4 gene, which is predicted to encode a Rab GAP in C.
elegans. All known Rab GAPs contain a highly conserved TBC domain which is
essential for Rab GAP function, and the TBC-4 protein is predicted to contain a single
TBC domain; therefore, it is likely that the tbc-4 gene encodes a Rab GAP in C. elegans.
In addition, the resistance of a tbc-4 mutant to exogenous dopamine suggests that the
regulation of Rab GTPase activity may be influenced by dopamine signaling, and this
regulation may provide a mechanism through which dopamine controls acetylcholine
release.
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CHAPTER II
MATERIALS AND METHODS
Worm genetics

Strains
All worm strains were maintained at 20º under standard conditions (unless
otherwise noted), and all double and triple mutants were generated using standard
methods (Brenner 1974). The strains used in this study were: N2 Bristol, ace-2(g72) I,
goa-1(sa734) I, egl-30(tg26) I, eat-16(ad702) I, aex-6(sa24) I, cat-2(e1112) II, rab3(js49 II), glr-1(nd38) III, rbf-1(js232) III, dat-1(ok157) III, dop-2(vs105) V, dgk1(sy428) X, aex-3(js814) X, dop-3(vs106) X, dop-1(vs100) X, ace-1(nd35) X, tbc4(ok3041) X.

Isolation of dopamine resistant mutants
N2 animals were mutagenized with ethyl methanesulfonate and cultured on NGM
plates. Staged L4 F1 progeny were cloned to individual wells of untreated flat-bottomed
96 well plates, each well containing 50 µL of OD550=10 OP50 culture suspended in S
complete media. Plates were grown at 20 C for three days in a plastic container lined
with moistened paper towels. Cultures were then washed three times in water and tested
for resistance to 120 µL of a 40 mM liquid dopamine solution. Mutants were isolated as
resistant if 25 percent of a well remained thrashing in dopamine solution for more than
four minutes. Primary isolates were immediately rescued, and several clones were
inoculated into liquid culture to homozygose the mutation. Clones whose progeny were
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greater than 75 percent resistant to 40 mM liquid dopamine were deemed dopamine
resistant and the mutants were subsequently mapped and outcrossed on 40 mM dopamine
plates.

SNP mapping of screen isolates
Isolates were mapped to a chromosome by mating to the polymorphic mapping
strain CB4856, identifying cross-progeny, and rehomozygosing the dopamine resistance
of the mutation in the F2 generation. Since the mutation was homozygosed in the N2
Bristol background, PCR and digestion analysis of a panel of single nucleotide
polymorphisms (SNPs) located at the center of each chromosome was used to identify the
chromosome on which the mutation is present based on recombination frequency (Wicks
et al. 2001). This same strategy was applied to fine-map the location of the mutations to
specific regions of a chromosome using a panel of chromosome-specific SNPs.

Genetic complementation
For complementation analysis of screen isolates, mutants in candidate genes were
crossed into PD4788 males expressing myo-2::GFP (Edgely et al. 1999), and F1
heterozygote males were selected based on fluorescence of the pharyngeal muscle. These
animals were then crossed into prospective isolates from the screen, and heterozygotes
from this cross were then tested for dopamine resistance.
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Two-factor positional mapping
For two-factor mapping of the ace-1(nd35) mutation, the dyn-1(ky51) X and sup10(n983) X mutations were used as flanking visible markers. dyn-1 animals are uncoordinated (Unc) at 25º, and sup-10 mutants are long, egg-laying defective, and uncoordinated (Sup) (Clark et al. 1997; Greenwald and Horvitz 1985). As sup-10(n983)
masks the phenotype of dyn-1(ky51) animals, mapping recombinants could only be
selected that were Dyn-non-Sup. The recombinant chromosome was homozygozed
through self-fertilization and selection of Dyn-never-Sup populations, and the resultant
populations were assayed for dopamine resistance.

Generation and analysis of transgenic animals

Tissue-specific rescue of DOP-3 and DOP-1
For tissue-specific rescue of DOP-3 in the cholinergic motor neurons of dat-1;
dop-3 mutants, 50 ng/µL of pCL31 (acr-2::GFP) and 25 ng/µL of pCL34 (acr-2::DOP3) were co-injected with 15 ng/µL of pJK4 (myo-2::GFP). For tissue-specific rescue of
DOP-3 in the GABAergic motor neurons of dat-1; dop-3 mutants, 50 ng/µL of pCL32
(unc-47::GFP) and 25 ng/µL of pCL35 (unc-47::DOP-3) were co-injected with 15 ng/µL
of pJK4 (myo-2::GFP). For tissue-specific rescue of DOP-3 in the cholinergic and
GABAergic neurons of dat-1; dop-3 mutants, 50 ng/µL of pCL31 and pCL32 were coinjected with 25 ng/µL of pCL34 and pCL35. For tissue-specific rescue of DOP-3 in the
cholinergic motor neurons of dop-3 ace-1 mutants, 50 ng/µL of pCL31 and 25 ng/µL of
pCL34 were co-injected with 15 ng/µL of pJK4. For tissue-specific rescue of DOP-1 in
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the cholinergic motor neurons of dop-3 dop-1 ace-1 mutants, 50 ng/µL of pCL31 and 25
ng/µL of pCL33 (acr-2::DOP-1) were co-injected with 15 ng/µL of pJK4. Five
independent transgenic lines were established for each experimental group, and 50 L4
animals from each line were selected that displayed the most complete expression of GFP
in the cholinergic or GABAergic motor neurons and assayed for the appropriate behavior.
Five control lines carrying the empty vector for each experimental condition were
generated and assayed in parallel. All transgenic lines were generated using standard
methods (Mello et al. 1991), and all constructs were derived from the pPD49.26 vector
(Addgene) using standard sub-cloning procedures. acr-2 is a cholinergic neuron specific
promoter (Hallam et al. 2000), and unc-47 is a GABAergic neuron specific promoter
(Eastman et al. 1999).

Rescue of dopamine sensitivity in tbc-4 mutants using a full-length TBC-4 PCR product
A 12.5 kb fragment of genomic DNA containing the complete coding sequence of
TBC-4, 5 kb of 5’ upstream regulatory sequence, and 1 kb of 3’ UTR was amplified
using the Qiagen LongRange PCR kit (Qiagen). 50 ng/µL of PCR product was coinjected with 25 ng/µL of pJK4 into tbc-4(ok3041) animals. Five independent transgenic
lines were established based on pharyngeal GFP florescence, and 50 young adult animals
from each line were selected and assayed for the exogenous dopamine resistance. Five
control lines carrying only pJK4 were generated and assayed in parallel.
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Determination of the expression pattern of tbc-4
A 12 kb fragment of genomic DNA containing 9 kb of sequence upstream from
the predicted start codon of TBC-4 and the entire 3 kb of the first intron was fused to
GFP amplified from pPD49.77 (Addgene) using PCR fusion (Hobert 2002). 50 ng/µL of
the PCR product was co-injected with 50 ng/µL of pL15EK into lin-15(n765ts) animals,
and three independent transgenic lines were established based on the rescue of the
multiple vulva phenotype (Muv) of lin-15 animals at 20º.
For localization of tbc-4 expression to the cholinergic motor neurons, the dop1::RFP integrated line LX797 was crossed into tbc-4::GFP males and cross-progeny
were identified by florescence microscopy.
For co-localization of TBC-4 with RAB-3, transgenic animals expressing rab3::mCherry were created by injecting 50 ng/µL of pJORG1901 (rab-3::mCherry) (a kind
gift of Erik Jorgensen) with 50 ng/µL of pL15EK into lin-15(n765ts) animals and
isolating transgenic lines by the rescue of the Muv phenotype. Then, rab-3::mCherry
animals were crossed into tbc-4::GFP males and cross-progeny were identified by
florescent microscopy.
All images were taken with a Cool Snap EZ camera on a Nikon Eclipse FN1
microscope equipped with epiflouresence using a 60x oil immersion objective. All
imaged animals were immobilized with 2mM levamisole and mounted on microscope
slides containing 2% agarose. Merged images were created using Nikon Elements
imaging software.
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Behavioral analysis of mutants

Dopamine response
10 young adults for each strain to be assayed were incubated undisturbed for 4
minutes on plates containing 40 mM dopamine, and then scored for paralysis. Animals
were considered paralyzed when they were not able to exhibit at least one spontaneous
body bend in a 5 sec period. A body bend was defined as the movement of the posterior
bulb of the pharynx through either a minimum of maximum amplitude. Assays were
repeated five times for a total of 50 animals per strain. Dopamine plates were prepared as
previously described (Chase et al. 2004).

Dopamine dose-response
25 young adults for each strain to be assayed were incubated undisturbed for 10
minutes on plates containing the indicated concentration of dopamine, and then scored
for paralysis. Animals were considered paralyzed when they were not able to exhibit at
least one spontaneous body bend in a 5 sec period. Assays were repeated in duplicate for
a total of 50 animals per strain.

Chronic aldicarb exposure
Chronic aldicarb sensitivity assays were done as previously described (Miller et
al. 1999). Briefly, enough L4 animals of each strain were cloned to aldicarb plates of the
indicated concentration to spawn 300 progeny on a drug-free NGM plate and allowed to
grow at 20º for 96 hours. The resultant progeny were counted and data was plotted as the
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percent population size as compared to the no drug control. Each condition was tested in
triplicate for all strains.

Acute aldicarb exposure
1 mM aldicarb plates were made by adding a 0.5 M stock solution to molten lowsalt agar at 55º to a final concentration of 1 mM. Plates were stored inverted in the dark
at room temperature for 24 hours, then stored at 4º and used within one week. Plates
were allowed to equilibrate at room temperature for 30 minutes prior to the assay. 25
adult animals were picked away from food and placed in the center of a 1mM aldicarb
plate and prodded sharply every five minutes with a platinum worm pick and scored for
paralysis. Paralysis was defined as the inability to exhibit at least one body bend in a five
second period following prodding. Each assay was done in duplicate for a total of 50
animals per strain.

Basal slowing
Basal slowing assays were done as previously described (Chase et. al. 2004).
Briefly, the locomotion rates of staged young adult animals were quantified by counting
the number of body bends completed in 5 consecutive 20-second intervals in the presence
and the absence of HB101 bacteria. Data was collected for 6 animals per condition for a
total of 30 measurements per condition. Percent slowing was calculated by dividing the
difference between locomotion rates on and off food by the locomotion rate off food.
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Swimming induced paralysis
10 L4 animals were picked away from food and placed in a 50 uL water droplet
on a Menzel Glaser 10-well diagnostic slide #X1XER308B# and scored for movement
after 10 minutes. Movement was scored as the presence of the alternating C-bends
characteristic of C. elegans swimming behavior (Pierce-Shimomura et al. 2008). In the
case of locomotion-defective mutants, movement was scored as the continual exhibition
of spontaneous body bends (as defined above). This assay was repeated for a total of 50
animals per strain.

Egg laying
Egg laying assays were done as previously described (Chase and Koelle 2004).
Briefly, 30 staged young adult animals for each strain were dissolved in 20 %
commercial bleach and the eggs held in utero were counted for each animal within 5
minutes.

Sequence analysis of Rab GAPs

Domain comparison of Rab GAPs
Predicted protein sequences of selected Rab GAPs were obtained from the NCBI
protein database (http://www.ncbi.nlm.nih.gov/) and the predicted domains contained
within the coding sequence were determined using Protein SMART (http://smart.emblheidelberg.de/). Proteins were graphically aligned to illustrate the location of the TBC-4
domain in all selected sequences.
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Sequence alignment of Rab GAPs
Protein sequences of selected Rab GAPs were aligned using ClustalX multiple
sequence alignment software (http://www.clustal.org/). The ALN file was then processed
using the BoxShade online server (http://www.ch.embnet.org/software/BOX_form.html)
to visually represent conserved amino acid residues (v3.2.1).
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CHAPTER III
RESULTS

Screen isolates suggest that dopamine controls acetylcholine release by modulating the
activity of the cholinergic motor neurons
We completed a clonal liquid screen of 31,241 mutagenized haploid genomes for
mutants resistant to the paralytic effects of exogenous liquid dopamine (Fig. 3.1). We
identified seven mutants from the screen (Table 3.1) that were subsequently mapped and
outcrossed four times using 40 mM dopamine plates as the selective criteria, as it proved
difficult to re-homozygose mutants using the liquid dopamine assay. From the screen,
we identified four previously identified components of dopamine signaling in C. elegans,
including the D2-like receptor DOP-3. These results confirm that our genetic screening
method is an effective tool to isolate mutants in endogenous dopamine signaling
components.
In addition, this screen could be continued as it is not fully saturated. It is
estimated that in approximately every 2,000 ethylmethanesulfonate mutagenized C.
elegans haploid genomes, a mutation is caused in each gene in the genome (Anderson
1995). Despite the fact that we screened enough mutagenized haploid genomes to achieve
five-fold coverage of the entire genome, we failed to isolate two previously identified
components of dopamine signaling in C. elegans, the Gβ5 subunit GPB-2 and the RGS
protein EAT-16 (Chase et al. 2004). However, we did isolate multiple alleles of DGK-1
and a gain-of-function allele in the Gαq homolog EGL-30.
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These results indicate that although the screen was approaching saturation, increasing the
amount of genomes screened could potentially identify additional components required
for dopamine signaling.

Figure 3.1. Design of a clonal liquid screen to identify mutants resistant to
exogenous dopamine. F1 progeny of mutagenized P0 animals were cloned to individual
wells of a 96 well plate and cultured in liquid until F2 populations reached adulthood.
These cultures were then washed to remove culture media and tested for dopamine
resistance. Plates were screened for wells in which one quarter of the population was
dopamine resistant. Each well was founded by a single F1 hermaphrodite heterozygous
for mutations in potential genes of interest, and one quarter of the F2 progeny of that
animal will therefore be both homozygous for the mutation(s) and dopamine resistant.
Gene
goa-1
dgk-1
egl-30
dop-3
glr-1

Alleles
nd64
nd48,
nd55
nd50
nd41
nd38

Mutations
IVS7+1G>A
Q520X,
G721E
D151N
IVS2-1G>A
S668T

ace-1

nd35

Q84X

Protein
G-protein alpha subunit
Diacylglycerol kinase

Human ortholog
Gαο
DGKθ

G-protein alpha subunit
D2-like 7TM receptor
AMPA-type glutamate-gated
cation channel subunit
Acetylcholinesterase

Gαq
D2 7TM receptor
GluR2
Acetylcholinesterase

Table 3.1. Genes and mutations identified in the dopamine resistance screen. Seven
alleles of six genes were identified from a forward genetic screen of over 31,000
mutagenized haploid genomes. Four genes identified were in previously identified
15

components of dopamine signaling (Chase et al. 2004), and all genes identified are
conserved in the mammalian brain. All mutations were identified via direct sequencing
of purified PCR amplicons (GeneWiz, https://clims3.genewiz.com/default.aspx). Closest
human orthologs were identified by protein sequence comparison using ClustalX.
Our screen also identified two mutants in components not previously implicated
in dopamine signaling. We identified a gain-of-function mutant in the glutamate-gated
cation channel subunit GLR-1 and a loss-of-function mutant in the class A
acetylcholinesterase ACE-1.
GLR-1 is homologous to the mammalian AMPA receptor subunits in the brain
(56% identity to RatGluR1) that collectively play an important role in fast excitatory
neurotransmission and long-term memory (Jonas 1993; Manilow and Malenka 2002).
GLR-1 is expressed in the five pairs of command interneurons which control the
direction of locomotion (Chalfie et al. 1985; Brockie et al. 2001), and it is known that
these neurons synapse onto the cholinergic motor neurons of the ventral nerve cord which
directly control body wall muscle contraction through the release of the neurotransmitter
acetylcholine (White et al. 1986; Richmond and Jorgensen 1999). The glr-1(nd38)
mutation identified in the screen causes a semi-dominant hyper-reversal phenotype, and
we proposed that it causes the GLR-1 channel to remain constitutively open, leading to
abnormal over-stimulation of the cholinergic motor neurons and thus dopamine
resistance. This hypothesis is supported by previous work in which transgenic worms
carrying a constitutively open copy of GLR-1 exhibits a hyper-reversal phenotype (Zheng
et al. 1999). The mutation present in the transgenic line was originally identified in Mus
musculus as a spontaneous mutant with a staggering gait, and was named the Lurcher
mutation (Phillips 1960). The Lurcher mutation was subsequently identified as an
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alanine-to-threonine change in a highly conserved third transmembrane region of the δ2
subtype of the M. musculus glutamate-gated cation channel which results in a
constitutively open channel (Zuo et al. 1997). The glr-1 mutant identified in our genetic
screen phenocopies the hyper reversal phenotype of the transgenic GLR-1(A/T) worms,
and sequencing analysis demonstrates that the glr-1(nd38) mutation is in the same third
transmembrane domain of GLR-1 as the Lurcher mutation (Fig. 3.2A). Therefore, we can
conclude that glr-1(nd38) mutants are resistant to exogenous dopamine due to an increase
in the excitability of the cholinergic motor neurons caused by over-stimulation from the
command interneurons, most likely due to the presence of a constitutively open channel.
ACE-1 is homologous to mammalian acetylcholinesterase, which degrades
acetylcholine in both synaptic terminals and neuromuscular junctions. ACE-1 is
expressed in the body wall muscles of C. elegans and has been shown to function
redundantly with ACE-2 to facilitate a wild-type rate of acetylcholine turnover in the
synaptic cleft (Culotti et al. 1981; Culetto et al. 1999). The ace-1(nd35) mutation
identified in the screen was a nonsense mutation early in the ACE-1 coding sequence and
is presumed to be a null allele based on the mutation’s proximity to the ace-1(p1000)
mutation (Fig. 3.2B), whose protein product has been shown to have no
acetylcholinesterase activity in vitro (Johnson et al. 1981). As ace-1(nd35) mutants are
resistant to exogenous dopamine, it is likely that dopamine is controlling acetylcholine
release, as a loss-of-function mutation in ace-1 would presumably increase the amount of
acetylcholine in the synaptic cleft and cause over-stimulation of the innervated muscle,
resulting in resistance to exogenous dopamine.
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Figure 3.2. Screen isolates contain mutations in conserved domains of proteins
required for neurotransmission. A.) Top: Sequence alignment of the third
transmembrane (TMIII) domains of Rattus norvigicus δ2 and C. elegans GLR-1
glutamate-gated cation channel subunits displays a high degree of conservation between
the two proteins. Bottom: Sequence comparison of Lurcher mutant (Lrch(-/-)) δ2 and
glr-1(nd38) mutant GLR-1 demonstrates that both mutations are in residues contained in
TMIII. Both Lrch(-/-) and glr-1(nd38) alleles are missense mutations that alter the
polarity of the affected amino acid and presumably affect the insertion of TMIII into the
membrane of the presynaptic terminal resulting in a leaky channel, a hypothesis
confirmed by both physiological and behavioral analysis of the Lrch(-/-) mutation (Zuo et
al. 1997; Zheng et al. 1999). Black boxes indicate identical amino acid residues. Open
arrowhead indicates the location of the Lrch(-/-) mutation in δ2. Closed arrowhead
indicates the location of the glr-1(nd38) mutation in GLR-1. Dashed line indicates the
SSYTANLAAF motif shared amongst most glutamate-gated cation channel subunits.
Numbering is from the first amino acid of TMIII. B.) Sequence alignment of wild-type
ACE-1 with ace-1(p1000) and ace-1(nd35) mutant ACE-1 suggests that both mutant
genes are likely to encode null alleles of ACE-1. ACE-1 protein encoded by ace-1
(p1000) is known to be truncated at W84 and has been shown to have 0% class A
acetylcholinesterase activity in vitro (Johnson et al. 1981). Sequencing of ace-1(nd35)
reveals a similar nonsense mutation in approximately the same location in the ace-1 gene,
consistent with the hypothesis that both mutants encode non-functional ACE-1. Dashes
indicate amino acids not encoded in the mutant alleles of ace-1. Bold dashes indicate the
site of the p1000 and nd35 nonsense mutations. Numbering begins at S66.
The isolation of both a gain-of-function mutation in GLR-1 and a loss-of-function
mutation in ACE-1 in a screen for mutants resistant to exogenous dopamine supports the
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model that dopamine signaling controls locomotion by modulating the excitability of the
cholinergic motor neurons and thus acetylcholine release.

Behavioral analyses of ace-1 and glr-1 mutants support the model that dopamine is
controlling acetylcholine release
To confirm our hypothesis that dopamine is modulating acetylcholine release in
the worm, we conducted a behavioral analysis of the ace-1 and glr-1 mutants recovered
from the screen. We chose to examine several dopamine-dependent behaviors to
evaluate the role of dopamine signaling in acetylcholine release.
We first chose to characterize the ace-1 and glr-1 mutations by observing the
resistance of the mutants to exogenous dopamine over time (Figure 3.3). ace-1 mutants
are weakly resistant to exogenous dopamine and, in fact, are less resistant than dop-3
mutants, suggesting that ACE-1 is acting downstream of the DOP-3 receptor, a
conclusion supported by the expression of ACE-1 in body wall muscle post-synaptic to
the cholinergic motor neurons (Culetto et al. 1999). glr-1 mutants, however, exhibit a
resistance to exogenous dopamine that more closely resembles that of goa-1 loss-offunction mutants. This suggests that GLR-1 is stimulating the cholinergic motor neurons
upstream of the DOP-3 receptor, a conclusion that is again supported by the expression of
GLR-1 exclusively in the command interneurons presynaptic to the cholinergic motor
neurons that express DOP-3 (Brockie et al. 2001). Together, these results demonstrate
that resistance to exogenous dopamine is conferred by mutations in genes that either
increase the level of or longevity of acetylcholine release from the cholinergic motor
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neurons (glr-1, ace-1) or decrease the inhibition of acetylcholine release from these
neurons (dop-3).

Figure 3.3. ace-1 and glr-1 mutants are resistant to exogenous dopamine. Dopamine
resistance is a well-established paradigm for assessing the role of various molecular
components in dopamine signaling (Chase et al. 2004). Both ace-1(nd35) and glr1(nd38) mutants are resistant to exogenous dopamine, demonstrating that both ACE-1
and GLR-1 are required for the wild-type response to exogenous dopamine. The strong
resistance of glr-1(nd38) demonstrates that GLR-1 modulates cholinergic motor neuron
excitability upstream of DOP-3, whereas the weaker resistance of ace-1(nd35)
demonstrates that ACE-1 is regulating cholinergic activity downstream of DOP-3.
Together, these results suggest that signaling through DOP-3 modulates acetylcholine
release by decreasing the excitability of the cholinergic motor neurons. Young adult
animals were picked away from food and onto plates of the indicated dopamine
concentration and assayed for the ability to make spontaneous body bends after 10
minutes of exposure. n=25 animals per strain. Experiments were done in duplicate for a
total of 50 animals per strain. Error bars represent the standard error of the mean.
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In C. elegans, there are several behaviors that are known to require dopamine
signaling for their proper execution. More importantly, a subset of these behaviors have
been shown to require signaling through the DOP-3 receptor to control locomotion. It
has previously been shown that wild-type animals reduce their rate of locomotion in
response to food, and that this basal slowing response is dependent on dopamine
signaling through the DOP-3 receptor (Sawin et al. 2000; Chase et al. 2004). Therefore,
we reasoned that if dopamine signaling was controlling acetylcholine release, both ace-1
and glr-1 mutants should be defective in the basal slowing response. Our experimental
results confirm that both ace-1 and glr-1 mutants are defective in the basal slowing
response, and subsequent genetic analysis of ace-2(g72) and ace-2; ace-1 mutants reveals
that dopamine signaling through the DOP-3 receptor reduces acetylcholine release to
facilitate the basal slowing response (Fig. 3.4).
These results together demonstrate that signaling through the DOP-3 receptor
conditionally regulates acetylcholine release, and that this regulation likely occurs in the
cholinergic motor neurons. However, as the precise mechanisms governing both
exogenous dopamine response and the basal slowing response are not entirely clear, we
decided to establish a more robust paradigm to examine dopamine signaling specifically
in the cholinergic motor neurons
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Figure 3.4. Signaling through the DOP-3 receptor decreases acetylcholine release in
response to food. The basal slowing response has been shown to require signaling
through the DOP-3 pathway, and mutants defective in this response are likely to harbor
mutations in genes important for dopamine signaling. Both glr-1(nd38) and ace-1(nd35)
are defective in the basal slowing response. ace-1(nd35) and ace-2(g72) both exhibit a
partial defect in slowing, which suggests redundant function of ACE-1 and ACE-2. The
ace-2; ace-1 double mutant, however, exhibits a complete defect in basal slowing like
dop-3, which demonstrates that signaling through the DOP-3 receptor decreases
acetylcholine release in response to food to facilitate the basal slowing response. L4
hermaphrodites were staged 14-19 hrs prior to the assay at 20º. Body bends were
counted for five 20-second intervals for 6 young adult worms per strain for a total of 30
independent measurements per condition. White bars indicate locomotion rate in the
absence of food, and black bars indicate locomotion rate in the presence of food. Error
bars represent the 95% confidence interval. Asterisks indicate slowing based on a
Student's t test (p<0.005) and daggers indicate a defect in basal slowing as compared to
the wild-type (†= p<0.025;††= p<0.0005).
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SWIP is a behavior that is controlled by DOP-3 receptor signaling in the cholinergic
motor neurons
Previously, it has been shown that mutants in the conserved dopamine transporter
DAT-1 become paralyzed when forced to engage in vigorous motor activity, a behavioral
defect referred to as swimming induced paralysis (SWIP) (McDonald et al. 2007). DAT1 is expressed in the eight dopaminergic neurons of C. elegans, where it has been shown
to not only recycle extrasynaptic dopamine, but also to directly modulate neural function
through a channel

Figure 3.5. SWIP is a dopamine-dependent behavior regulated by DOP-3 in the
cholinergic motor neurons. A.) The SWIP phenotype of dat-1 mutants is rescued in
the dat-1; dop-3 double mutant, demonstrating that the SWIP response is mediated by
excess signaling through the DOP-3 receptor. B.) Rescue of DOP-3 in either the
cholinergic or GABAergic motor neurons with cell-specific promoters rescues the SWIP
phenotype in a dat-1; dop-3 double mutant background, demonstrating that DOP-3 is
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mediating the SWIP response in the ventral cord motor neurons. acr-2 is a cholinergic
motor neuron specific promoter, and unc-47 is a GABAergic motor neuron specific
promoter. Bars represent the average of five trials of 10 L4 animals each for a total of 50
animals per strain. Error bars represent the 95% confidence interval. Asterisks represent
statistical difference between two bars by Student t test (p<0.005).
mechanism (Jayanthi et al. 1998; Carvelli et al. 2004). In addition, it has also been
shown that SWIP is mediated through the DOP-3 receptor, as the dop-3(vs106) mutation
rescues the SWIP phenotype of dat-1 animals (McDonald et al. 2007). These
observations together suggest a model where in a dat-1 mutant, extrasynaptic dopamine
accumulates in the worm and over-stimulates DOP-3 receptors on the cholinergic motor
neurons, leading to an inhibition of acetylcholine release and flaccid paralysis. We set
out to test this model by performing tissue-specific rescue of DOP-3 in both the
cholinergic and GABAergic motor neurons of dat-1;dop-3 mutants, and our results
confirm the model that DOP-3 is functioning in the cholinergic motor neurons to mediate
SWIP (Fig. 3.5). These results establish the cholinergic motor neuron of C. elegans as a
model system for the direct investigation of DOP-3 signaling and its role in acetylcholine
release.

SWIP analysis of GPCR mutants and screen isolates support the model that dopamine is
controlling acetylcholine release by modulating the excitability of the cholinergic motor
neurons
Once we established that SWIP was a behavior mediated by DOP-3 signaling in
the cholinergic motor neurons, we decided to investigate the role of various other
components shown previously to be required for inhibition of acetylcholine release in the
SWIP response (Fig. 3.6). The phenotype of the cat-2::CAT-2 mutant provides further
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evidence that SWIP is a dopamine-dependent behavior, as these animals over-express
tyrosine hydroxylase (the rate limiting enzyme of dopamine biosynthesis) in the
dopaminergic neurons and presumably have elevated levels of endogenous dopamine
(Fig. 3.6A). Also, the glr-1 and ace-1 mutations partially rescue the SWIP phenotype of
dat-1 mutants, providing further evidence that DOP-3 receptor signaling is attenuating
acetylcholine release, a conclusion supported further by the diminished SWIP response of
ace-2; ace-1; dat-1 triple mutants (Fig. 3.6A). Analysis of the effects of goa-1, eat-16,
dgk-1, and egl-30(gf) mutations on the SWIP phenotype of dat-1 mutants demonstrates
that these molecular components are inhibiting acetylcholine release in conjunction with
or in parallel to DOP-3 in the cholinergic motor neurons (Fig. 3.6B). Interestingly, we
also observed a partial SWIP phenotype in dop-2(vs105) mutants (Fig. 3.6C). We have
established that SWIP is a phenotype caused by a DOP-3–mediated reduction in
acetylcholine release, and this observation coupled with the expression of DOP-2 in the
dopaminergic neurons (Suo et al. 2003) suggests that DOP-2 may function as an autoreceptor that negatively regulates the release of dopamine in response to high endogenous
levels of the neurotransmitter. Finally, we also observed that the dop-1(vs100) mutation
not only failed to rescue the SWIP phenotype of dat-1 animals, but it also antagonized the
effects of the dop-3 (vs106) mutation in the dop-1 dop-3; dat-1 triple mutant (Fig. 3.6C).
These results suggest that DOP-1 may be antagonizing DOP-3 receptor signaling in the
cholinergic motor neurons; however, as DOP-1 is expressed in many neurons in C.
elegans, additional experiments are necessary to demonstrate that this antagonism is in
fact occurring in the same cell.

25

26

Figure 3.6. The SWIP phenotype is the result of excess acetylcholine release from
the cholinergic motor neurons. A.) Animals over-expressing the tyrosine hydroxylase
CAT-2 (the rate-limiting enzyme in dopamine biosynthesis) exhibit a strong SWIP
phenotype, demonstrating that SWIP is mediated by excess dopamine signaling. glr1(nd38) and ace-1(nd35) mutants both partially fail to rescue the SWIP response in a dat1 mutant background, demonstrating that SWIP depends on decreased acetylcholine
release from the cholinergic motor neurons. This observation is further supported by the
less severe phenotype of the ace-1; ace-2; dat-1 triple. B.) Mutants in inhibitory
components of dopamine signaling rescue the SWIP response in a dat-1 mutant
background, demonstrating that these components are influencing dopaminergic control
of acetylcholine release in the cholinergic motor neurons. C.) The dop-1(vs100)
mutation fails to rescue the SWIP phenotype of dat-1 mutants, but antagonizes the wildtype phenotype of dat-1;dop-3 double mutants, suggesting that DOP-1 may antagonize
DOP-3 receptor signaling in the cholinergic motor neurons. Also, dop-2 mutants exhibit
partial SWIP, suggesting that DOP-2 may function as an auto-receptor that downregulates dopamine release. Bars represent the average of five trials of 10 L4 animals
each for a total of 50 animals per strain. Error bars represent the 95% confidence
interval. Asterisks represent statistical difference from N2 by Student t test (* = p<0.005,
**=p<0.001) and the statistical difference between two bracketed bars (*** = p<0.005).
DOP-1 and DOP-3 act antagonistically in the cholinergic motor neurons to
modulate the release of acetylcholine
As a final confirmation of the role of DOP-3 in controlling acetylcholine release
from the cholinergic motor neurons, we conducted a genetic analysis of acetylcholine
release using acute exposure to the acetylcholinesterase aldicarb. Aldicarb is a wellestablished paradigm for the analysis of neuromuscular junction activity in C. elegans, as
wild type animals become paralyzed in response to aldicarb in a dose-dependent manner
(Nguyen et al. 1995). Mutants that exhibit increased acetylcholine release are sensitive
to the paralytic effects of aldicarb, whereas mutants that release diminished levels of
acetylcholine exhibit aldicarb resistance (Mahoney et al. 2006). Therefore, conclusions
can be drawn about a mutation’s effect on acetylcholine release based on its response to
aldicarb, establishing aldicarb response as a powerful genetic tool to identify and
characterize components involved in neurotransmitter release.
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If dopamine signaling is controlling acetylcholine release, dop-3, ace-1, and glr-1
mutants are all expected to exhibit sensitivity to the paralytic effects of aldicarb. In
addition, previous studies have used aldicarb sensitivity as a means to conduct tissuespecific rescue experiments (Lackner et al. 1999), an approach that we decided to
implement to directly investigate the antagonism of DOP-1 and DOP-3 receptor signaling
in the cholinergic motor neurons.
Surprisingly, we did not observe significant sensitivity of either ace-1 or dop-3
mutants to 1 mM aldicarb exposure, although sensitivity was observed for glr-1 mutants
(Fig. 3.7A). While these results are consistent with the model of dopamine signaling
acting to exert subtle modulation of neurotransmission (Bam ford et al. 2004), we
decided to adopt a more sensitive assay to investigate the cholinergic activity of both ace1 and dop-3 mutants, and in fact both mutants were observed to exhibit aldicarb
sensitivity in this assay (see Appendix A). In addition, the ace-1 dop-3 double mutant is
sensitive to acute aldicarb exposure, demonstrating an additive effect of these two
mutations that increases acetylcholine release (Fig. 3.7A). Furthermore, ace-1; ace-2
mutants show enhanced sensitivity to aldicarb as compared to either single mutant (Fig.
3.7A), supporting the conclusion that ace-1 and dop-3 mutants do in fact exhibit
increased cholinergic activity.
The sensitivity of the glr-1 mutation to aldicarb is most likely caused by an overstimulation of the cholinergic motor neurons upstream of the DOP-3 receptors. In the
glr-1 mutant, DOP-3 is still presumably functioning to inhibit acetylcholine release
despite the over-stimulation the neuron is receiving from the constitutively-active
command interneurons in these mutants. Thus, we reasoned that the dop-3(vs106)
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mutation should further increase the aldicarb sensitivity of glr-1 mutants, and when
tested, the glr-1; dop-3 double mutant is more sensitive to aldicarb than glr-1 mutants
alone, demonstrating that DOP-3 is in fact acting to inhibit acetylcholine release from the
cholinergic motor neurons (Fig. 3.7B).
To demonstrate that DOP-3 is inhibiting acetylcholine release in the cholinergic
motor neurons, we rescued DOP-3 in ace-1 dop-3 double mutants using the cholinergic
motor neuron-specific promoter acr-2 (Hallam et al. 2000) and observed their response to
aldicarb (Fig. 3.7C). These transgenic animals exhibit the wild-type level of aldicarb
sensitivity seen in ace-1 single mutants, demonstrating that DOP-3 is inhibiting
acetylcholine release specifically in the cholinergic motor neurons.
Once it was established that DOP-3 was acting specifically in the cholinergic
motor neurons to inhibit acetylcholine release, we decided to address the role of DOP-1
receptor signaling in acetylcholine release using aldicarb sensitivity. To investigate the
issue of DOP-1 and DOP-3 antagonism in the cholinergic motor neurons, we first chose
to observe the aldicarb sensitivity of ace-1 dop-1 dop-3 triple mutants (Fig. 3.7C).

If

DOP-1 antagonizes DOP-3 receptor signaling, then ace-1 dop-1 dop-3 mutants should
exhibit wild-type resistance to aldicarb, as the effects of the dop-1 mutation should
counteract the additive effects of the dop-3 and ace-1 mutations on acetylcholine release.
Analysis of these mutants supports this model, demonstrating that DOP-1 does in fact
antagonize DOP-3 receptor signaling and its effects on acetylcholine release.
Next, we sought to demonstrate that DOP-1 antagonizes DOP-3-mediated
inhibition of acetylcholine release in the cholinergic motor neurons, a hypothesis
supported by the co-localization of DOP-1 and DOP-3 to these cells and cell-specific
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rescue of exogenous dopamine resistance (Chase et al. 2004). To answer this question,
we created transgenic ace-1 dop-1 dop-3 animals expressing DOP-1 under the expression
of the cholinergic motor neuron-specific promoter acr-2 and observed their sensitivity to
aldicarb (Fig. 3.7C). If DOP-1 is antagonizing DOP-3 signaling in the cholinergic motor
neurons, then rescue of DOP-1 in these neurons of ace-1 dop-1 dop-3 mutants should
increase the aldicarb sensitivity of these animals by relieving the antagonistic effect of
the dop-1 mutation on the additive effects of the ace-1 and dop-3 mutations on
acetylcholine release. Analysis of these mutants supports this model, demonstrating that
DOP-1 and DOP-3 have antagonistic effects on acetylcholine release in a single cell: the
cholinergic motor neuron.
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Figure 3.7. DOP-1 and DOP-3 act antagonistically in the cholinergic motor neurons
to modulate the release of acetylcholine. A.) Mutants with increased levels of
acetylcholine release are sensitive to the paralytic effects of the acetylcholinesterase
inhibitor aldicarb. Surprisingly, dop-3 and ace-1 mutants that have been shown to exhibit
increased acetylcholine release do not show sensitivity to aldicarb. However, dop-3 ace1 double mutants exhibits aldicarb sensitivity, demonstrating an additive effect of these
mutations on acetylcholine release. Also, a similar additive effect can be seen in the
ace2; ace-1 double mutant. B.) The sensitivity of glr-1(nd35) mutants (which exhibit
constitutive activation of the cholinergic motor neurons) is exacerbated in the glr-1; dop3 double mutant, demonstrating that DOP-3 functions to inhibit the release of
acetylcholine from the cholinergic motor neurons. C.) Expression of DOP-3 in the
cholinergic motor neurons of dop-3 ace-1 animals rescues the aldicarb resistance of these
animals to wild-type levels, demonstrating that DOP-3 is regulating acetylcholine release
in the cholinergic motor neurons. D.) Expression of DOP-1 in the cholinergic motor
neurons of dop-3 dop-1 ace-1 animals rescues the aldicarb sensitivity of these animals to
that of the dop-3 ace-1 double mutant, demonstrating that signaling through the DOP-1
receptor is antagonizing DOP-3 signaling in the cholinergic motor neurons to modulate
acetylcholine release. n=25 young adult animals per strain. Assays were done in
duplicate for a total of 50 animals per strain. Error bars represent standard error of the
mean.
tbc-4 mutants are defective in the exogenous dopamine response
During the process of mapping the screen isolate later identified as ace-1, we
identified another gene involved in dopamine response. Using intra-chromosomal SNP
mapping, we mapped the position of the mutation to less than 2 cam on the far right end
of the X chromosome. However, mapping genes located at the ends of chromosomes is
complicated by the paucity of visible genetic markers available for use in three-factor
genetic mapping. As a means to circumvent this problem, we adopted a candidate
approach to map the mutation: we identified potential candidate genes from the C.
elegans genome based on both their location near the end of chromosome X and their
predicted biological function. We then obtained deletion mutants of these genes and
examined their sensitivity to exogenous dopamine. A mutation in one of these genes, the
putative Rab GTPase activating protein tbc-4, caused resistance to exogenous dopamine
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(Fig. 3.8A), suggesting that it may be allelic to the mutation isolated in the screen.
However, the results of genetic complementation between the two mutations
demonstrated that they were non-allelic and thus mutations in two separate genes.
Although ace-1 was later mapped and cloned using two-factor genetic mapping, the
candidate approach was successful in identifying tbc-4 as a novel component in
dopamine response.

Figure 3.8. The dopamine resistance of tbc-4 mutants can be rescued by TBC-4
under the expression of its own promoter. A.) tbc-4(ok3041) mutants are resistant to
exogenous dopamine. B.) Transgenic tbc-4 mutants expressing TBC-4 under its own
promoter are no longer resistant to exogenous dopamine, demonstrating that the
dopamine resistance seen in tbc-4(ok3041) mutants is in fact a result of the loss of TBC-4
function. White bars represent the average of five trials of 10 young adult animals for a
total of 50 animals per strain. Colored bars represent the average of five trials of 10
young adults for each of five transgenic lines for a total of 250 animals per bar. Asterisks
represent the difference between two bars by Student t test (p<0.005).
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To further demonstrate that TBC-4 was in fact required for exogenous dopamine
response, we generated transgenic tbc-4 animals expressing TBC-4 under its own
promoter and assayed these animals for dopamine sensitivity (Fig. 3.8B). The rescue of
dopamine sensitivity in these transgenic animals illustrates that TBC-4 is in fact required
for sensitivity to exogenous dopamine and suggests a role for Rab-mediated vesicular
trafficking in facilitating dopaminergic control of locomotion.

TBC-4 closely resembles the mammalian Rab GAP EPI64
Once we had established that TBC-4 is likely playing a role in dopamine
signaling, we decided to investigate the likely targets and action of TBC-4 in C. elegans.
Preliminary sequence analysis verified the presence of a TBC domain in the TBC-4
amino acid sequence (Fig. 3.9), a domain conserved in all previously characterized Rab
GAPs from yeast to man (Bernard’s 2003) with one notable exception (Fukui et al.
1997). This sequence analysis also revealed the absence of any additional conserved
domains, which presumably play a role in defining the specificity and function of Rab
GAPs to one or a subset of Rabs. However, these observations allowed a comparison of
TBC-4 to Rab GAPs in other species (Fig. 3.9), which revealed that TBC-4 closely
resembles the mammalian Rab GAP EPI64, which has been shown to exhibit GAP
activity specifically towards the AEX-6 homolog Rab27A in a melanocytes (Itoh and
Fukuda 2007).
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Figure 3.9. Schematic comparison of the domain compositions of several Rab GAPs
suggest that TBC-4 most closely resembles the human Rab GAP EPI64. The amino
acid sequences of several Rab GAPs were selected and their domain structure was
determined using the Protein SMART online server. All sequences selected contained
the TBC domain stereotypical of Rab GAP proteins and were diagramed to illustrate the
variety of Rab GAP domain structures both within and across species. TBC: Tre2/Bub2/Cdc16 domain. PTD: Phosphotyrosine-binding domain. CC: Coiled-coil
domain. TLD: Domain in TBC and LysM-containing proteins. Scale represents an
approximate number of amino acid residues.
A subsequent alignment of the TBC-4 amino acid sequence with several other
closely related Rab GAPs further suggests that TBC-4 is most similar to EPI64 and may
function in the same capacity as a Rab GAP for AEX-6 (Fig. 3.10). However, these
observations do not exclude the possibility that TBC-4 exhibits GAP activity towards
several Rabs, as several regulators of Rab activity have been shown to modify the activity
of more than one Rab (Mahoney et al. 2006, Ishibashi et al. 2008).
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Figure 3.10. Sequence alignment of selected Rab GAPs demonstrates that TBC-4 is
most similar to EPI64. Despite the conservation across all selected Rab GAPs of the
TBC domain critical for GAP activity, TBC-4 shares a higher degree of similarity with
EPI64. ClustalX was used to align the amino acid sequence of several Rab GAPs.
Shading was done using the online BoxShade server. Black shading indicates identical
residues. Grey shading indicates similar residues. The three conserved motifs essential
for GAP function (RxxxW, IxxDxxR, and YxQ) (Pan et al. 2006) are indicated below the
alignment with a solid line.
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TBC-4 is expressed in the nervous system of C. elegans and co-localizes with RAB-3 in
the cholinergic motor neurons
To further characterize the role of TBC-4 in neurotransmission, we determined
the expression pattern of TBC-4 by observing the florescence of transgenic animals
carrying a tbc-4::GFP reporter (Fig. 3.11). The expression pattern of TBC-4 has been
previously reported, but the promoter used in that study included only 2.2 kb of the first
intron of the tbc-4 ORF (Hunt-Newbury et al. 2007). In our study, we used the first 9 kb
of 5’ upstream regulatory sequence in addition to the first 3.2 kb of the tbc-4 ORF
(including the first exon and the entire first intron) as the promoter to drive GFP
expression (Fig. 3.11A). By using this approach, we determined that TBC-4 is expressed
in the pharyngeal muscle, ventral cord motor neurons, and select neurons of the head and
tail (Fig. 3.11B), an expression pattern consistent with those of both RAB-3 and AEX-6
(Nonet et al. 1997; Mahoney et al. 2006). Subsequent analysis revealed that TBC-4 was
likely expressed in the neurons of the tail that regulate defecation (Fig. 3.11C), a behavior
previously established to be mediated by AEX-6 (Thomas 1990). In addition, TBC-4
expression was also observed in the vulval muscle (Fig. 3.11D) post-synaptic to the
hermaphrodite specific neurons where RAB-3 has been previously shown to localize
(Patel et al. 2006). This data demonstrates that TBC-4 is expressed throughout the
nervous system of C. elegans in a pattern consistent with that of RAB-3 and AEX-6 and
therefore suggests the possibility of TBC-4 acting in the same cells to regulate the
activity of these Rabs. To further investigate the possibility of TBC-4 regulating the
activity of presynaptic Rabs, we analyzed the co-expression of tbc-4::GFP with
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florescent reporters for both DOP-1, a marker for the cholinergic motor neurons, and
RAB-3 (Fig. 3.12).

Figure 3.11. TBC-4 is expressed in the nervous system of C. elegans. A.) A GFP
reporter construct was generated using a 12 kb promoter (including the first intron)
amplified from genomic DNA and fused to a fragment amplified from pPD49.77
containing the GFP coding sequence and the unc-54 3' UTR using PCR fusion. 50 ng/µL
of the PCR product was co-injected with 50 ng/µL of the L15EK rescue construct into
lin-15(n765ts) animals and transgenic lines were isolated by the absence of the MuV
phenotype at 20º. B.) TBC-4 is expressed in the pharyngeal muscle (1), the nerve ring
(2), the ventral nerve cord (3), and neurons of the tail (4). Arrow indicates two
unidentified interneurons that may be command interneurons. C.) TBC-4 expression is
seen in several neurons of the tail which may regulate defecation in C. elegans. D.)
TBC-4 is expressed in vulval muscle. All images taken with a Cool Snap EZ camera on a
Nikon Eclipse FN1 equipped with epiflouresence using either a 10x (B) or 60x oil
immersion objective. All imaged animals were immobilized with 2mM levamisole and
mounted on microscope slides containing 2% agarose.
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Figure 3.12. TBC-4 is co-expressed with RAB-3 in the cholinergic motor neurons.
A.) tbc-4::GFP expression largely overlaps with rab-3::mCherry expression in animals
expressing tbc-4::gfp and rab-3::mcherry, suggesting the possibility of a direct
interaction between TBC-4 and RAB-3. B.) tbc-4::GFP expression largely overlaps with
dop-1::RFP expression in the cholinergic motor neurons of transgenic animals expressing
both tbc-4::gfp and dop-1::rfp, which demonstrates that TBC-4 is expressed in the
cholinergic motor neurons. In both (A) and (B), tbc-4::GFP is expressed in cells other
than those expressing either dop-1::RFP or rab-3::mCherry, suggesting that TBC-4 may
be expressed in cells other than the cholinergic motor neurons. All images taken with a
Cool Snap EZ camera on a Nikon Eclipse FN1 microscope equipped with epiflouresence
using a 60x oil immersion objective. All imaged animals were immobilized with 2mM
levamisole and mounted on microscope slides containing 2% agarose. Merged images
were created using Nikon Elements imaging software.
As a result of this analysis, we have determined that TBC-4 co-localizes with both DOP1 and RAB-3 in the cholinergic motor neurons of the ventral nerve cord (Fig. 3.12), and
as RAB-3 and RAB-27 have been shown to be co-localized in these cells, this data
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suggests that TBC-4 may act in these neurons to regulate locomotion by regulating the
activity of a presynaptic Rab. In addition, we also observed neurons expressing tbc4::GFP in the ventral nerve cord that did not overlap with dop-1::RFP expression. As the
dop-1::RFP transgene used in this study was integrated using UV/TMP-associated
integration (), all cells in these transgenic animals that express DOP-1 will also express
RFP, and as DOP-1 is expressed in all of the cholinergic motor neurons of the ventral
nerve cord, the presence of tbc-4::GFP-expressing cells in the ventral cord that do not colocalize with dop-1::RFP (Fig. 3.12B, large arrow) demonstrates that TBC-4 must be
expressed in additional cells of the ventral cord. These cells are likely GABAergic motor
neurons, a hypothesis supported by the localization of the GABAergic motor neurons in
the ventral nerve cord (White et al. 1986, Schuske et al. 2004). This observation is
intriguing, as DOP-3 expression has also been shown in both the cholinergic and
GABAergic motor neurons of the ventral cord (Chase et al. 2004), further suggesting a
possible role for TBC-4 in dopaminergic regulation of locomotion.

TBC-4 decreases acetylcholine release and antagonizes RAB-3
Sequence and expression analysis have identified TBC-4 as a putative regulator of
Rab activity at the presynaptic terminal, and the resistance of tbc-4 mutants to exogenous
dopamine suggests that TBC-4 is playing a role in regulating dopaminergic
neurotransmission. As we have established that dopamine signaling controls locomotion
by regulating the release of acetylcholine from the presynaptic terminals of cholinergic
motor neurons, we sought to observe the role of TBC-4 in acetylcholine release through a
behavioral analysis of the tbc-4(ok3041) mutant.

41

Egg laying in C. elegans is a well-characterized behavior that is stimulated by
serotonin release from the hermaphrodite-specific neurons (HSNs) and inhibited by
acetylcholine release onto G-protein coupled acetylcholine receptors expressed on the
HSNs, and mutants with increased acetylcholine release have been shown to hold more
eggs in utero as compared to the wild-type (Bany et al. 2003, Fig. 3.13A) which
establishes egg laying as a behavioral read-out of endogenous acetylcholine release. As a
preliminary assessment of the role of TBC-4 in acetylcholine release, we sought to
observe the effects of the tbc-4(ok3041) mutation on egg laying behavior (Fig. 3.13B).
Our results indicate that while tbc-4 mutants exhibit wild-type egg laying
behavior, dop-3 tbc-4 mutants are defective in egg laying, which demonstrates an
additive effect of these genes’ negative regulation of acetylcholine release in the egg
laying circuit. This observation is supported by previous evidence that dopamine inhibits
egg laying through D2-like receptors (Weinshenker et al. 1995). In addition, the tbc4(ok3041) mutation antagonizes the egg laying defect of rab-3 mutants. RAB-3 has been
shown to be expressed at the presynapse of the HSNs (Patel et al. 2006) and as we have
shown that TBC-4 is expressed in the adjacent vulval muscle innervated by the HSNs, it
is plausible that TBC-4 may negatively regulate RAB-3-mediated control of
neurotransmitter release in the HSNs.
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Figure 3.13. Mutations in dopamine signaling and vesicular trafficking components
have additive or antagonistic effects on acetylcholine release. A.) While ace-1
mutants exhibit moderate egg-laying defects, dop-3 mutants show no phenotype and ace1 dop-3 double mutants do not exacerbate the phenotype of the ace-1 mutant. B.) rab-3
mutants exhibit a moderate defect in egg-laying behavior and tbc-4 mutants exhibit wildtype egg-laying behavior, but the phenotype of the dop-3 tbc-4 double mutant
demonstrates an additive increase in acetylcholine release. In addition, rab-3; tbc-4
double mutants exhibit a minor egg-laying defect that demonstrates an antagonistic
relationship between RAB-3 and TBC-4. Each bar represents the average egg count of
30 staged young adult animals dissolved in 20% hypochlorite solution. Bars represent
the standard error of the mean. Asterisks represent the difference from wild-type by
Student t test (*=p<0.005) and the statistical difference between two bracketed bars (** =
p<0.05).
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TBC-4 and DOP-3 both antagonize RAB-3- and AEX-6 –mediated acetylcholine release
in response to exogenous dopamine
To further investigate the role of vesicular trafficking in dopaminergic regulation of
acetylcholine release, we examined the response of mutants defective in presynaptic
vesicular trafficking components to exogenous dopamine (Fig. 3.14). To begin this
analysis, we first needed to demonstrate resistance to exogenous dopamine is conferred
by altered cholinergic activity. Analysis of ace-1 and ace-2 mutants demonstrates that
resistance to exogenous dopamine is in fact the result of increased cholinergic activity
(Fig. 3.14A), and thus, resistance to exogenous dopamine can be used as a behavioral
assessment of acetylcholine release. Subsequent analysis of mutations in vesicular
trafficking components demonstrate that positive regulators of RAB-3-and AEX-6mediated vesicular docking antagonize the dopamine resistance of both dop-3 (Fig.
3.14B) and tbc-4 (Fig. 3.14C,D) mutants, which supports the model of dopamine
signaling modulating acetylcholine release through the regulation of vesicular docking.

DOP-3 selectively antagonizes RAB-3 in response to food
To investigate the role of vesicular docking in endogenous dopamine signaling,
we chose to observe the ability of mutants in components of presynaptic vesicular
docking to slow in response to food (Fig. 3.15). As a result of this analysis, we observed
that mutations in the positive regulatory components of RAB-3-mediated vesicular
docking cause a loss of the basal slowing response, and that these components appear to
antagonize the effects of TBC-4 and DOP-3 (Fig. 3.15A).
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Figure 3.14. DOP-3 signaling is regulated by RAB-3- and AEX-6-mediated
vesicular trafficking. A.) The dopamine resistance of dop-3 mutants is due to increased
acetylcholine release, as supported by the dopamine resistance of ace-1, ace-2, and ace1; ace-2 double mutants. B.) Double mutants between positive regulators of vesicle
docking and dop-3 reduce the dopamine resistance conferred by the dop-3 mutation,
demonstrating an antagonistic relationship between vesicular docking and DOP-3
receptor signaling. C.) The dopamine resistance of tbc-4 is antagonized by RAB-3 and
dependent on dopamine signaling as demonstrated by the diminished dopamine resistance
of the cat-2; tbc-4 double mutant. D.) The dopamine resistance of tbc-4 is antagonized
by mutations in positive regulatory components of vesicular docking. Bars represent the
averages of 5 trials of 10 animals each for a total of 50 animals per strain. Error bars
represent the standard error of the mean. Asterisks represent the statistical difference
from wild-type (* = p<0.001) and the statistical difference between two bracketed bars
(**=p<0.005).
In contrast to these findings, mutations in the positive regulatory elements of AEX-6mediated vesicular docking do not cause a loss of the basal slowing response, and do not
antagonize the effects of DOP-3 (Fig. 3.15B). Interestingly, although the tbc-4(ok3041)
mutation has no effect on the phenotype of rab-3 mutants, aex-6; tbc-4 double mutants
show a significant defect in basal slowing. These two observations support the model
that RAB-3- but not AEX-6-mediated vesicular docking is required for the basal slowing
response. In addition, we observed that mutations in AEX-6-mediated vesicular docking
components disrupt the rate of locomotion of animals in the absence of food despite
having no effect on the ability of the animal to slow in response to food, which when
incorporated with our other observations suggests different roles for AEX-6 and RAB-3
in facilitating locomotion: RAB-3, like DOP-3, may only facilitate modulation of
acetylcholine release under specific conditions such as slowing in response to food,
whereas AEX-6 may play a broader role in mediating the overall locomotion rate of C.
elegans independent of dopamine-specific regulation of acetylcholine release.
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Figure 3.15. Mutants in dopamine signaling and vesicular trafficking components
are defective in the basal slowing response. A.) tbc-4 mutants have a minor defect in
basal slowing and the tbc-4(ok3041) mutation does not alter the defects of dop-3 or rab-3
mutants, and mutants in positive regulatory components of RAB-3-mediated vesicular
docking are defective in basal slowing and antagonize the basal slowing defect of dop-3.
B.) The tbc-4(ok3041) mutation alters the wild-type basal slowing response of aex-6
mutants, likely through a synthetic effect, and mutants in positive regulatory components
of AEX-6-mediated vesicular docking are not defective in basal slowing and do not
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antagonize the basal slowing defect of dop-3. L4 hermaphrodites were staged 14-19 hrs
prior to the assay at 20º. Body bends were counted for five 20-second intervals for 6
young adult worms per strain for a total of 30 independent measurements per condition.
White bars indicate locomotion rate in the absence of food, and black bars indicate
locomotion rate in the presence of food. Error bars represent the 95% confidence
interval. Asterisks indicate slowing based on a Student's t test (p<0.005).
Mutations in RAB-3 but not AEX-6 vesicular docking components rescue the SWIP
phenotype of dat-1mutants.
As SWIP is a behavior mediated by dopamine signaling in the cholinergic motor
neurons, we sought to observe the effects of mutations in vesicular docking components
on the SWIP phenotype of dat-1 mutants (Fig. 3.16). Analysis of these mutants
demonstrates that the SWIP phenotype requires RAB-3 and TBC-4, but not AEX-6 or
AEX-3. These observations are consistent with the model that RAB-3 function is
required for the exhibition of specific dopamine-dependent behaviors, whereas AEX-6 is
not. It is surprising, however, that the aex-3(js814) mutation has no effect on the SWIP
phenotype of dat-1 mutants, as AEX-3 has been shown to promote the activity of both
RAB-3 and AEX-6 (Mahoney et al. 2006). It is also surprising that mutations in both
tbc-4 and rab-3 rescue the SWIP phenotype of dat-1 mutants, as this suggests that both
RAB-3 and TBC-4 are required to inhibit acetylcholine release, an observation which is
supported by the functional role of TBC-4 as a Rab GAP but counter-intuitive to the
predicted function of a Rab GTPase. However, this observation is not unprecedented, as
Rab3A has been demonstrated to inhibit neurotransmitter release under certain conditions
in the mammalian nervous system (Geppert et al. 1997).
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Figure 3.16. Mutations in rab-3 and tbc-4 rescue the SWIP phenotype of dat-1
mutants. rab-3 and tbc-4 mutations rescue the SWIP phenotype of dat-1 mutants,
demonstrating that mutations in these genes increase acetylcholine release. In contrast,
aex-6 and aex-3 mutations fail to rescue the SWIP phenotype of dat-1 mutants,
suggesting that mutations in these genes do not increase acetylcholine release. Bars
represent the average of five trials of 10 L4 animals each for a total of 50 animals per
strain. Error bars represent the 95% confidence interval. Asterisks represent statistical
difference from N2 by Student t test (* = p<0.005, **=p<0.001) and the statistical
difference between two bracketed bars (*** = p<0.005).
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CHAPTER IV
DISCUSSION
Dopamine receptor signaling is a critical mechanism by which neurotransmission
is regulated, and further investigation into the molecular pathways activated downstream
of the receptors is crucial to achieve a better understanding of how the two classes of
dopamine receptors interact to modulate neural activity. Here we provide evidence that
dopamine acts through two antagonistic receptors to modulate acetylcholine release from
the cholinergic motor neurons. We also characterize a novel component of dopamine
signaling, the Rab GAP TBC-4, and demonstrate that vesicular docking mediated by the
presynaptic Rabs RAB-3 and AEX-6 have distinct functional roles in facilitating
locomotion in C. elegans despite their mutual regulation by TBC-4. Our results support a
model of dopaminergic regulation of vesicular trafficking as one possible mechanism by
which dopamine receptor signaling acts to modulate neural activity.

DOP-3 signaling inhibits acetylcholine release from the cholinergic motor neurons
D2-like receptors are characterized by their inhibitory effect on cAMP-dependent
processes in the mammalian brain (Neve et al. 2004), and the C. elegans D2-like receptor
DOP-3 has similarly been shown to inhibit neurotransmission (Chase et al. 2004). The
expression pattern of DOP-3 in the ventral cord motor neurons in addition to its clear role
in regulating locomotor activity suggests that signaling through the DOP-3 receptor
inhibits acetylcholine release. Here we present several lines of evidence that demonstrate
this hypothesis to be true. The isolation of both the glr-1(nd38) and ace-1(nd35)
mutations from a genetic screen for mutants resistant to exogenous dopamine directly
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correlates increased acetylcholine release with dopamine resistance. In addition, we
demonstrate that the basal slowing response, a well-defined dopamine-dependent
behavior, is facilitated through a DOP-3-mediated decrease in acetylcholine release.
Furthermore, we establish SWIP as a dopamine-dependent behavior that is mediated by a
DOP-3-mediated inhibition of acetylcholine release in the motor neurons of the ventral
cord. Finally, we demonstrate through the use of acute aldicarb exposure not only that
dop-3 mutants exhibit increased acetylcholine release, but also that DOP-3 plays an
active role in decreasing the release of acetylcholine from the hyper-activated cholinergic
motor neurons of glr-1 mutants. These observations firmly establish that DOP-3 receptor
signaling inhibits acetylcholine release from the cholinergic motor neurons, a conclusion
that supports mammalian studies of D2-like receptor inhibition of the tonically-active
cholinergic interneurons of the striatum (Aosaki et al. 1994, Deng et al. 2007).

DOP-1 antagonizes DOP-3 signaling in the cholinergic motor neurons
While it is well established that D1- and D2-like dopamine receptors can exert
either antagonistic or synergistic effects on neurotransmission (Neve et al. 2004), the
underlying mechanism(s) for these interactions are largely unknown. Furthermore, it has
been widely observed that the antagonism or synergism between these two receptorsignaling pathways occurs amongst different cells expressing only one class of receptor at
detectable levels (Gerfen et al. 1990), although there is increasing evidence for D1- and
D2-like receptor co-expression in specific cell types (Lee et al. 2004, Geldwert et al.
2006). Here we demonstrate that in C. elegans, DOP-1 antagonizes the inhibitory
signaling of DOP-3 in the cholinergic motor neurons to modulate acetylcholine release
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from these cells in the behaving worm. This is the first report to our knowledge of
functional D1- and D2-like receptor antagonism within a single cell in vivo. This
observation is an expected consequence of receptor co-expression and further supports
evidence that D1- and D2-like receptors can function in a single cell to exert specific
effects on neurotransmission (Lee et al. 2004). The variety of responses that can be
elicited from interactions of D1- and D2-like receptors is impressive, and includes the
formation of both homodimers and heterodimers (Lee et al. 2000) and synergistic or
antagonistic receptor signaling between two cell types or within a single cell (Gerfen et
al. 1990, Surmeier et al. 2007). This large array of signaling modalities is supported by
the expression of roughly equal concentrations of heterogeneously expressed D1- and
D2-like receptors in the medium spiny neurons of the striatum (Surmeier et al. 1996,
Geldwert et al. 2006), thereby enabling the diverse mechanisms by which dopamine can
regulate neurotransmission in these cells. The heterogeneous expression of D1- and D2like receptors is conserved in C. elegans, as the sub-cellular localization of the DOP-1
and DOP-3 receptors supports this model (Kathryn Maher, unpublished data).
Furthermore, we have shown that DOP-1 antagonism of DOP-3 provides a mechanism
through which to modulate acetylcholine release, a finding that supports studies of the
aspiny cholinergic interneurons of the striatum, where dopamine has been shown to alter
the firing rate of these neurons to facilitate associative learning (Aosaki et al.
1994,Watanabe and Kimura 1998, Deng et al. 2007, Pisani et al. 2001).
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TBC-4 is a Rab GAP in C. elegans with specificity for the presynaptic Rabs RAB-3 and
AEX-6
As a result of our genetic screen to isolate mutants resistant to exogenous
dopamine, we identified the putative Rab GAP TBC-4 as necessary component of
exogenous dopamine response. Sequence analysis and comparison of the amino acid
sequence of TBC-4 demonstrates that TBC-4 is indeed a Rab GAP, and that it closely
resembles the mammalian Rab 27A-GAP EPI64. In mammalian cell culture, EPI64
regulates the activity of Rab 27A in melanocytes (Itoh and Fukuda 2006), but the C.
elegans homolog of Rab 27A, AEX-6, is expressed presynaptically in the motor neurons
of the ventral nerve cord along with the Rab 3A homolog RAB-3, where both Rabs
facilitate neurotransmission (Nonet et al. 1997,Mahoney et al. 2006). Subsequent
analysis of the expression pattern of TBC-4 revealed that TBC-4 was co-expressed in the
cholinergic motor neurons with RAB-3, which suggested the possibility that these two
proteins interact in vivo. Genetic analysis of the cholinergic inhibition of egg laying in
tbc-4 and rab-3 mutants demonstrates that TBC-4 inhibits acetylcholine release and
opposes RAB-3 facilitation of neurotransmission in the egg-laying circuit. These
observations were further supported by a genetic analysis of dopamine resistance that
revealed not only that dopamine resistance is caused by excess acetylcholine release, but
also that both DOP-3 and TBC-4 antagonize RAB-3- and AEX-6-mediated vesicle
trafficking through a dopamine-dependent mechanism. These results combined
demonstrate that TBC-4 can exhibit GAP activity towards RAB-3 and AEX-6, and that
this GAP activity is at least partially facilitated by dopamine signaling.
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RAB-3 and AEX-6 facilitate synaptic transmission in distinctly different capacities
Behavioral analysis of dopamine-dependent TBC-4 regulation of cholinergic
motor neuron activity revealed that while RAB-3 was required for dopamine-dependent
inhibition of synaptic transmission, AEX-6 was not. Also, we found that while TBC-4
was required for dopamine-dependent inhibition of RAB-3, TBC-4 does not inhibit
AEX-6 activity in response to dopamine. Therefore, AEX-6-mediated neurotransmission
is not altered by the context-specific release of dopamine, whereas both TBC-4 and RAB3 function is dramatically altered. These observations collectively support the model of
RAB-3 and AEX-6 facilitating neurotransmission in separate and distinct capacities.
AEX-6 facilitates acetylcholine release from the cholinergic motor neurons
(Mahoney et al. 2006) and its activity is not altered by dopamine signaling (our results).
However, the locomotion rate of aex-6 mutants is significantly slower than that of wildtype animals (Thomas 1990), which is not true of rab-3 mutants (Nonet et al. 1997, our
observations). These observations together suggest that AEX-6 acts to tonically regulate
the output of the cholinergic motor neurons independent of context-specific stimuli (Fig.
4.1) as a possible component of the C. elegans central pattern generator which has been
previously observed to require synchronization of both GABAergic and cholinergic
output (Karbowski et al. 2008), or that AEX-6 activity may be regulated by additional
context-specific cues (Fig. 4.1B).
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Figure 4.1. Dopamine signaling through DOP-3 may limit the quantal release of
acetylcholine through a RAB-3-mediated mechanism. A.) In the absence of
dopamine signaling through DOP-3, RAB-3 mediates the docking of loaded vesicles to
the active zone of the presynaptic terminal and AEX-6 facilitates the association of
loaded vesicles with the SNAP-NSF complex (Nonet et al. 1997, Mahoney et al. 2006).
B.) RAB-3 inhibits acetylcholine release in response to dopamine signaling through
DOP-3, whereas AEX-6 signaling is unaffected.
RAB-3 appears to inhibit acetylcholine release in response to dopamine, which is
counter-intuitive to the well-established role of Rab proteins as facilitators of vesicle
docking and fusion (Zerial and McBride 2001), and is also contrary to the pre-established
role of RAB-3 in C. elegans as a facilitator of active-zone recruitment of synaptic
vesicles (Nonet et al. 1997). However, Rab3A has been shown to facilitate
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neurotransmission through two separate mechanisms. One of these mechanisms is the
recently well-established and highly-conserved recruitment of synaptic vesicles to the
presynapse through the formation of a tri-partite complex with Munc13 and Rim1a
(Weimer et al. 2006, Gracheva 2008, Dulubova et al. 2005) which increases the amount
of docked vesicles at the active zone ready for release. The other mechanism is the
limitation of quantal release of neurotransmitter at the active zone by a distortion of the
plasma membrane (Geppert et al. 1997, Wang et al. 2008). This mode of regulation is
unique to Rab3A and supports our observations of an inhibitory role of RAB-3 in C
elegans neurotransmission. Furthermore, our results support a context-specific “switch”
that reverses RAB-3 facilitation of neurotransmission in response to dopamine, possibly
through the activation of TBC-4 (Fig. 4.1B). This context-specificity may help to explain
the paradoxical role of Rab3A in neurotransmission in the mammalian brain and more
clearly define the role of Rab proteins in facilitating calcium-triggered quantal release
from presynaptic terminals in the central nervous system.
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APPENDIX
MUTANTS RESISTANT TO EXOGENOUS DOPAMINE BUT INSENSITIVE TO
HIGH DOSES OF ALDICARB DISPLAY ALDICARB SENSITIVITY AFTER
CHRONIC EXPOSURE TO LOW DOSES

dop-3 and ace-1 mutants are not sensitive to high concentrations of aldicarb, despite
direct evidence that these mutants have increased levels of acetylcholine release.
However, both ace-1 and dop-3 mutants are sensitive to chronic exposure of low levels of
aldicarb, as is the glr-1 mutant identified in the screen, consistent with the hypothesis that
mutations in inhibitory components of dopamine signaling result in increased
acetylcholine release. For each experiment, enough L4 animals were staged to lay
approximately 300 progeny 96 hours later on plates without aldicarb. Experiments for
each strain were done in triplicate, and results are plotted as the percent population
present on the no drug control plates.
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